JPMorgan Downgrades CENTA and HNST Ratings, Mixed Outlook Ahead of Earnings

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: Jan 16 2026

0mins

CENTA-0.59%

HNST+3.2%

CENT-0.62%

Should l Buy CENTA?

Source: seekingalpha

Rating Downgrade: JPMorgan downgraded Central Garden & Pet (CENTA) from Neutral to Underweight due to subdued demand in the pet category, projecting low single-digit sales and EPS growth, which reflects the company's reliance on the U.S. consumer and market uncertainties.
Increased Competitive Pressure: The firm issued a double downgrade for The Honest Company (HNST) from Overweight to Underweight, primarily due to heightened competition in the diaper market, which is expected to necessitate increased price promotions to maintain market share, impacting profitability.
Market Reaction: Following the downgrades, CENTA shares fell 3.3% in early Friday afternoon trading, while HNST shares dropped 3.1%, indicating heightened investor concerns about future performance and reflecting a cautious sentiment towards household personal care stocks.
Strategic Adjustments: The Honest Company is implementing a new productivity program that involves exiting lower-margin, non-strategic categories and channels, which, while aimed at improving efficiency, also necessitates finding new revenue sources to offset potential income losses, increasing future growth uncertainties.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy CENTA?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on CENTA

About CENTA

Central Garden & Pet Company is engaged in the garden and pet industries. The Company offers a portfolio of over 60 brands, including Amdro, Aqueon, Best Bully Sticks, Cadet, C&S, Farnam, Ferry-Morse, Kaytee, Nylabone, Pennington, Sevin, Zoecon, and JustiFLY. Its segments include Pet and Garden. The Pet segment includes dog and cat supplies such as treats and chews, toys, beds and containment, grooming products, waste management and training pads; supplies for aquatics, small animals, reptiles and pet birds including toys, enclosures and habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live fish and small animals as well as outdoor cushions. The Garden segment includes lawn and garden consumables such as grass seed; vegetable, flower and herb packet seed; wild bird feed, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products, and live plants.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

CENTRAL GARDEN & PET REVEALS EXPANSION OF STOCK REPURCHASE PROGRAM

Feb 17 2026moomoo

Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.

Central Garden & Pet Appoints New Board Member

Feb 12 2026Newsfilter

New Board Appointment: Central Garden & Pet Company has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, aiming to leverage her extensive experience in the animal health sector to drive company growth.
Rich Industry Experience: Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health until her retirement in February 2023, demonstrating her deep understanding of the company.
Leadership Recognition: Bill Brown, Chairman of the Board, stated that Schwichtenberg's leadership experience and profound understanding of consumer products and animal health will provide crucial support for the company's focus on innovation and long-term value creation, further enhancing corporate governance.
Outstanding Educational Background: Schwichtenberg holds an MBA from the University of Illinois at Chicago and completed the Advanced Executive Program at London Business School, showcasing her expertise in business management, which can significantly contribute to strategic decision-making within the company.

Central Garden & Pet Shareholders Re-Elect Directors and Approve Auditor

Feb 12 2026Yahoo Finance

Board Re-Election: During the 2026 annual meeting, all nine director nominees received at least 10,771,155 votes, ensuring stability in the company's governance structure and enhancing shareholder trust in management.
Auditor Approval: Shareholders ratified Deloitte as the independent auditor with 17,177,566 votes, reflecting the company's commitment to financial transparency and compliance, which is expected to boost investor confidence.
Executive Compensation Vote: The advisory vote on executive compensation received at least 16,346,943 votes in favor, indicating shareholder approval of the company's pay policies, which may help attract and retain key talent.
Meeting Procedures Smooth: The meeting confirmed the presence of at least 8,880,142 shares of common stock and 1,600,459 shares of Class B stock, ensuring a quorum was met, which facilitated the smooth progression of the agenda and demonstrated active shareholder engagement and interest in the company's future development.

Central Garden & Pet Company Q1 2026 Earnings Call Insights

Feb 05 2026seekingalpha

Financial Performance Overview: Central Garden & Pet reported net sales of $617 million for Q1, reflecting a 6% year-over-year decline primarily due to spring inventory shipment timing and portfolio optimization, although non-GAAP gross margin improved to 30.8%, indicating ongoing cost management efforts.
Acquisition and Innovation Strategy: The company completed the acquisition of Champion USA at quarter-end, enhancing its market position in the livestock sector, while management emphasized continued investments in digital capabilities and innovation to drive future organic growth.
Earnings Guidance Reaffirmed: Management reaffirmed its fiscal 2026 non-GAAP diluted EPS expectation of $2.70 or better, indicating confidence in future performance despite ongoing pressures from shipment timing and portfolio optimization.
Market Outlook and Challenges: Despite challenges from SKU rationalization and shipment timing, management expressed optimism about stabilization in pet categories and anticipated a positive market rebound during the spring gardening season, showcasing the company's potential for market share gains and long-term profitability.

CENTA Stock 52-Week High and Low Analysis

Feb 02 2026NASDAQ.COM

Price Range Analysis: CENTA's stock has a 52-week low of $25.93 and a high of $37.35, with the last trade recorded at $31.26, indicating significant price fluctuations within this range.
Market Performance Comparison: The current price of $31.26 represents a 20.67% increase from the 52-week low, yet it is 16.38% below the high, reflecting a cautious market sentiment towards the stock.
Technical Indicator Reference: The relationship between CENTA's stock performance and its 200-day moving average remains unclear, prompting investors to monitor whether the stock can sustain a breakthrough above this critical technical level.
Investor Sentiment Analysis: Although the current stock price is positioned in the middle of the 52-week range, market perceptions may be influenced by the overall economic environment and industry dynamics.